Sfoglia per AUTORE
CAIROLI R
Collezione AO Cuneo
Items : 9
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.
2023
ASL Torino 5
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
Coviello E; Cilloni D; Passamonti F; Corradini P; Bertù L; Guidetti A; Visco C; Pagano L; Gherlinzoni F; Galimberti S; Tisi MC; Cudillo L; Gentile M; Mohamed S; Visani G; Federici AB; Della Porta MG; Mauro FR; Gambacorti-Passerini C; Massaia M; Bocchia M; Scattolin A; Billio A; Marchesi F; Trentin L; Cattaneo C; Derenzini E; Fracchiolla NS; Romano A; et alii...
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.
2023
AOU Città della Salute di Torino
AO Cuneo
AO Ordine Mauriziano
AOU Novara
Martinelli G; Rossi G; Tarella C; Sciumè M; Marconi G; Abruzzese E; Cascavilla N; Rivellini F; Volpi R; Federico V; Gigli F; Roncoroni E; Romano A; Cardinali V; Nanni J; Maurillo L; Ferrara F; Lanza F; Cilloni D; Fianchi L; Lunghi M; Martini V; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Manfra I; Basilico CM; et alii...
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AOU Alessandria
Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Musto P; Coviello E; Romano A; Passamonti F; Corradini P; Krampera M; Tosi P; Lanza F; Candoni A; Selleri C; Conconi A; Visani G; Vallisa D; Venditti A; Gambacorti-Passerini C; Rigacci L; La Barbera EO; Corso A; Armiento D; Cilloni D; Cardinali V; Galimberti S; Bocchia M; et alii...
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):857-863. doi: 10.1002/hon.3060. Epub 2022 Aug 14.
2022
ASL Cuneo 1
ASL Città di Torino
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
Passamonti F; Corradini P; Fabbri E; Coviello E; Ruggeri M; Ferrero D; Venditti A; Romano I; Gentile M; Mecucci C; Gherlinzoni F; Mohamed S; Krampera M; Marchetti M; Massaia M; Arcaini L; Sacchi MV; Guidetti A; Ciceri F; Cairoli R; Monaco F; Lanza F;
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV. in Hematological oncology / Hematol Oncol. 2022 Dec;40(5):846-856. doi: 10.1002/hon.3048. Epub 2022 Aug 12.
2022
AO Cuneo
ASL Torino 5
AOU Città della Salute di Torino
Passamonti F; Arcaini L; Bruno R; Antonio Grossi P; Corradini P; Pagano L; Busca A; Giuliani N; Luppi M; Tosi P; Mohamed S; Corso A; Rigacci L; Giovanni Della Porta M; Lanza F; Venditti A; Massimo Lemoli R; Billio A; Gentile M; Falini B; Turrini M; Tafuri A; Morotti A; Chiara Tisi M; Galimberti S; Coviello E; Trentin L; Cuneo A; Bocchia M; et alii...
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.
2021
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara
Bertù L; Pagano L; Corradini P; Musto P; Petrucci L; Zaja F; Grossi PA; Visani G; Lanza F; Cattaneo C; Mina R; La Barbera EO; Cardinali V; Galimberti S; Luppi M; Armiento D; Candoni A; Krampera M; Fracchiolla N; Bocchia M; Marchesi F; Tafuri A; Pinto A; Arcaini L; Ladetto M; Massaia M; Busca A; Venditti A; Romano I; et alii...
Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors. in BMJ supportive & palliative care / BMJ Support Palliat Care. 2021 May 3:bmjspcare-2020-002312. doi: 10.1136/bmjspcare-2020-002312.
2021
AO Cuneo
Oswald LB; Venditti A; Cella D; Cottone F; Candoni A; Melillo L; Cairoli R; Storti G; Salutari P; Luppi M; Albano F; Martelli MP; Cuneo A; Tafuri A; Trisolini SM; Tieghi A; Fazi P; Vignetti M; Efficace F;
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. in Haematologica / Haematologica. 2021 Jun 1;106(6):1559-1568. doi: 10.3324/haematol.2020.247973.
2021
AOU Città della Salute di Torino
AO Cuneo
Vitale A; Cattaneo C; Mattei D; Fracchiolla N; Cerrano M; Cairoli R; Candoni A; Papayannidis C; De Fabritiis P; Di Raimondo F; Capria S; Apicella V; Spinelli O; Santoro A; Pierini V; Puzzolo MC; Lauretti A; Canichella M; La Starza R; Albertini Petroni G; Elia L; Ansuinelli M; Taherinasab A; Cavalli M; Cafforio L; Piciocchi A; Della Starza I; Messina M; Chiaretti S; et alii...
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia. in Blood / Blood. 2019 Sep 19;134(12):935-945. doi: 10.1182/blood.2018886960. Epub 2019 Aug 8.
2019
AO Cuneo
Amadori S; Arcese W; Lo-Coco F; Voso MT; Lavorgna S; Ottone T; Irno-Consalvo M; Del Principe MI; Buccisano F; Vignetti M; Maurillo L; Fazi P; La Sala E; Alati C; Fracchiolla NS; Capelli D; Foà R; Tieghi A; Chierichini A; Fabbiano F; Tafuri A; Cuneo A; Albano F; Mazza P; Martelli MP; Luppi M; Martinelli G; Lanza F; Storti G; et alii...